Cancer risk in multiple sclerosis: findings from British Columbia, Canada
Open Access
- 12 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 135 (10), 2973-2979
- https://doi.org/10.1093/brain/aws148
Abstract
Findings regarding cancer risk in people with multiple sclerosis have been inconsistent and few studies have explored the possibility of diagnostic neglect. The influence of a relapsing-onset versus primary progressive course on cancer risk is unknown. We examined cancer risk and tumour size at diagnosis in a cohort of patients with multiple sclerosis compared to the general population and we explored the influence of disease course. Clinical data of patients with multiple sclerosis residing in British Columbia, Canada who visited a British Columbia multiple sclerosis clinic from 1980 to 2004 were linked to provincial cancer registry, vital statistics and health registration data. Patients were followed for incident cancers between onset of multiple sclerosis, and the earlier of emigration, death or study end (31 December 2007). Cancer incidence was compared with that in the age-, sex- and calendar year-matched population of British Columbia. Tumour size at diagnosis of breast, prostate, colorectal and lung cancers were compared with population controls, matched for cancer site, sex, age and calendar year at cancer diagnosis, using the stratified Wilcoxon test. There were 6820 patients included, with 110 666 person-years of follow-up. The standardized incidence ratio for all cancers was 0.86 (95% confidence interval: 0.78–0.94). Colorectal cancer risk was also significantly reduced (standardized incidence ratio: 0.56; 95% confidence interval: 0.37–0.81). Risk reductions were similar by sex and for relapsing-onset and primary progressive multiple sclerosis. Tumour size was larger than expected in the cohort (P = 0.04). Overall cancer risk was lower in patients with multiple sclerosis than in the age-, sex- and calendar year matched general population. The larger tumour sizes at cancer diagnosis suggested diagnostic neglect; this could have major implications for the health, well-being and longevity of people with multiple sclerosis.Keywords
This publication has 37 references indexed in Scilit:
- Vitamin D and Nonmelanoma Skin Cancer in a Health Maintenance Organization CohortArchives of Dermatology, 2011
- Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studiesJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Cancer risk among patients with multiple sclerosis and their parentsNeurology, 2009
- Vitamin D and skin cancer: A meta-analysisEuropean Journal of Cancer, 2009
- Environmental risk factors for multiple sclerosis. Part II: Noninfectious factorsAnnals of Neurology, 2007
- Regulatory T Cells and Human DiseaseJournal of Immunology Research, 2007
- Cancer incidence in multiple sclerosis and effects of immunomodulatory treatmentsBreast Cancer Research and Treatment, 2005
- Skin cancer in people with multiple sclerosis: a record linkage studyJournal of Epidemiology and Community Health, 2004
- Trends in survival and cause of death in Danish patients with multiple sclerosisBrain, 2004
- Comorbid Illness and the Early Detection of CancerSouthern Medical Journal, 2001